Public Statement: Epoetins and the risk of tumour growth progression and thromboembolic events in cancer patients and cardiovascular risks in patients with chronic kidney disease

View source ↗

Summary

EMA public statement warning about risks associated with epoetins, including tumor progression, thromboembolic events in cancer patients, and cardiovascular ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chronic Kidney Disease